agreed to sell its remaining 7,750,000 shares of Alkermes plc.
In March 2012, Elan sold 24,150,000 shares of Alkermes in a public offering.
M2 EQUITYBITES-September 19, 2011-Alkermes
plc and Elan Corporation plc reports establishment of Dublin based Alkermes
plc(C)2011 M2 COMMUNICATIONS http://www.
DUBLIN -- Alkermes
plc (NASDAQ: ALKS) will host a conference call at 8:30 a.
DUBLIN -- Alkermes
plc (NASDAQ: ALKS) and Elan Corporation, plc (NYSE: ELN) ("Elan") today announced the completion of the merger between Alkermes
NASDAQ: ALKS) today announced that Alkermes
shareholders have approved the merger of Alkermes
and Elan Drug Technologies ("EDT"), the profitable drug formulation and manufacturing business unit of Elan Corporation, plc (NYSE: ELN) ("Elan").
At the meeting, members of Alkermes
' senior management and a guest speaker from Elan Drug Technologies (EDT) will provide an update on the merger of Alkermes
and EDT, including the combined company's outlook, commercial products, pipeline candidates and financial expectations.
Transaction Immediately Accretive to Cash Earnings; Alkermes
plc to be Immediately Profitable on a Cash Basis with Growing Revenues in Excess of $450 Million Annually --
developed, manufactures and commercializes VIVITROL([R]) for alcohol dependence and manufactures RISPERDAL([R]) CONSTA([R])for schizophrenia and bipolar I disorder.
is an exciting company and David leaves it in a strong position as we prepare for the approval of exenatide once weekly, complete the VIVITROL([R]) pivotal study to expand the label into the opioid dependence indication and expand our pipeline of innovative medicines," said Richard Pops.
is also providing a podcast MP3 file available for download on the Alkermes
website, which will be available shortly following the conference call and will be available until Thursday, November 13, 2008.
NASDAQ: ALKS) announced that it has received a letter terminating the development and license agreement between Eli Lilly and Company (Lilly) and Alkermes
dated April 1, 2001 thereby terminating the AIR([R]) Inhaled Insulin (AIR([R]) Insulin) program.